{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:03:01Z","timestamp":1780336981442,"version":"3.54.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["RO1 CK 000152"],"award-info":[{"award-number":["RO1 CK 000152"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015583","name":"American Lyme Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015583","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.amjmed.2023.04.001","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T01:44:45Z","timestamp":1681523085000},"page":"702-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Prospective Study to Characterize Symptoms and Symptom Severity in Adult Patients with Extracutaneous Manifestations of Lyme Disease"],"prefix":"10.1016","volume":"136","author":[{"given":"Gary P.","family":"Wormser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Scavarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Visintainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.amjmed.2023.04.001_bib0001","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1093\/cid\/ciz1215","article-title":"Prospective evaluation of the frequency and severity of symptoms in Lyme disease patients with erythema migrans compared with matched controls at baseline, 6 months, and 12 months","volume":"71","author":"Wormser","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2023.04.001_bib0002","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2018.11.039","article-title":"Evaluation of prospectively followed adult patients with erythema migrans using the Beck Depression Inventory second edition","volume":"132","author":"Wormser","year":"2019","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2023.04.001_bib0003","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3201\/eid2504.181509","article-title":"Co-infections in persons with early Lyme disease, New York, USA","volume":"25","author":"Wormser","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2023.04.001_bib0004","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.diagmicrobio.2016.07.026","article-title":"Fatigue in patients with erythema migrans","volume":"86","author":"Wormser","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2023.04.001_bib0005","doi-asserted-by":"crossref","first-page":"e1895--20","DOI":"10.1128\/AAC.01895-20","article-title":"Patients with erythema migrans: characterizing the impact of initiation of antibiotic therapy prior to study enrollment","volume":"65","author":"Wormser","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.amjmed.2023.04.001_bib0006","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2023.04.001_bib0007","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2023.04.001_bib0008","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.diagmicrobio.2018.12.001","article-title":"Higher C6 enzyme immunoassay index values correlate with a diagnosis of noncutaneous Lyme disease","volume":"94","author":"Nigrovic","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.amjmed.2023.04.001_bib0009","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/cid\/ciac863","article-title":"Racial difference in the diagnosis of Lyme disease in children","volume":"76","author":"Hunt","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2023.04.001_bib0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/aje\/152.8.756","article-title":"Racial differences in reported Lyme disease incidence","volume":"152","author":"Fix","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.amjmed.2023.04.001_bib0011","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.amjmed.2023.04.001_bib0012","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/srt.13113","article-title":"Skin measurement devices to assess skin quality: A systematic review on reliability and validity","volume":"28","author":"Langeveld","year":"2022","journal-title":"Skin Res Technol"},{"issue":"4","key":"10.1016\/j.amjmed.2023.04.001_bib0013","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/php.12607","article-title":"Diffuse reflectance spectroscopy versus Mexameter\u00ae MX18 measurements of melanin and erythema in an African population","volume":"92","author":"Wright","year":"2016","journal-title":"Photochem Photobiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323002413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323002413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:30:07Z","timestamp":1762079407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934323002413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0002934323002413"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.04.001","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Prospective Study to Characterize Symptoms and Symptom Severity in Adult Patients with Extracutaneous Manifestations of Lyme Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}